Hermes Intelligence, a pioneering data intelligence company, last month announced its official launch, bringing a revolutionary approach to the pharmaceutical industry. Unlike traditional data analytics providers, it specializes in harnessing the power of alternative data, transforming every online document, patient review, clinical trial detail, and drug pricing information into actionable insights that drive revenue, accelerate drug discovery, and enhance patient outcomes.
In an era where data is abundant but often fragmented, Hermes Intelligence recognizes the untapped potential of information scattered across the web. Indeed, more than 80% of the data is publicly available, yet most companies and individuals pay analytics providers for access or status. This system creates unnecessary data barriers and information asymmetry.
While traditional metrics like sales figures provide a snapshot of performance, they fail to capture the nuances of patient sentiment, competitor strategies, and market trends. Hermes Intelligence bridges this gap by offering comprehensive data collection, advanced natural language processing (NLP), and sophisticated analytics tailored specifically for the pharmaceutical sector. Under one single subscription model, on a pay as you go basis, moving away from expensive and inflexible licensing agreements.
"We're launching Hermes Intelligence to empower investors and pharmaceutical companies to unlock the hidden value of alternative data, transforming it into a strategic asset. By collecting and analyzing in real time, online patient reviews, competitor drug information, clinical trial data, regulatory filings, and more, we provide pharma organizations with the insights they need to make smarter decisions, accelerate research, and stay ahead of the curve." says Albion Begaj from Hermes Intelligence.
Some Examples of Hermes Intelligence Solutions:
Clinical Trials and Regulatory Filings
Processing and extracting insights from unstructured clinical trial reports, regulatory filings (beyond structured data), and patent documents using NLP and OCR.
Clinical Trials Count Across Sponsors – In Real Time
Powered by Hermes Intelligence
Key Event Reports
Extracting key information from key event reports and pharmacovigilance data to identify potential economic signals more efficiently.
ISM Hospital PMI – In Real Time
Powered by Hermes Intelligence
Hermes Intelligence aims to serve the pharmaceutical industry across all operators, from investors, research-focused biotechs to large multinational corporations, with the tools and expertise they need to thrive in the data-driven age. This will allow them to break down data barriers and information asymmetry across the industry. The company's innovative approach to alternative data analysis is poised to revolutionize the pharma sector, enabling operators to unlock hidden opportunities, accelerate innovation, and ultimately improve global health.
About Hermes Intelligence:
Hermes Intelligence is a leading cross sector alternative intelligence company with a focus in the pharmaceutical industry. Our mission is to redefine pharma intelligence and help organizations achieve sustainable growth, accelerate drug discovery, and improve patient lives.